Overview
The liver programme treats hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastases from colorectal and other primaries. Contrast-enhanced MRI and triple-phase CT establish lesion burden and portal vein status before any treatment decision.
Treatment pathways
Our centre performs TACE/TARE-class transarterial embolization, drug-eluting bead chemoembolization, percutaneous microwave and cryoablation, and iodine-125 seed implantation for lesions adjacent to major vessels. Portal vein tumour thrombosis is managed with combined interventional and systemic protocols.
What to expect
Most embolization procedures require a short hospital stay. Ablation patients are often discharged within one to two days. Liver function is monitored closely, and antiviral coverage is arranged for hepatitis B carriers.
Still have questions?
Reach our care team for personalized guidance on diagnosis, treatment, and insurance.
